title: Structure and in vitro function of human subcutaneous small arteries in mild heart failure.
abstract: The structure and function of subcutaneous small arteries from patients with mild heart failure (n = 27) 6-43 mo after myocardial infarction were compared with vessels from healthy control subjects (n = 10). Patients were randomized to treatment with placebo or the angiotensin-converting enzyme inhibitor ramipril starting 3-10 days after myocardial infarction. Dissected arterial vessels were mounted on a wire myograph for measurement of morphology and isometric tension. Morphology was not different in arteries from the three groups. Responses to norepinephrine, angiotensin II, and electrical field stimulation were similar in arteries from placebo-treated patients with mild heart failure and control subjects. Similarly, endothelium-dependent and -independent relaxation was normal in arteries from patients with mild heart failure. Ramipril therapy was associated with functional alterations: vasoconstrictor responses to norepinephrine and angiotensin II were significantly enhanced compared with placebo (P < 0.001). These data suggest that vascular structure and function are not different in vitro in subcutaneous arteries from placebo-treated patients with mild heart failure. Angiotensin-converting enzyme inhibitor therapy is associated with enhanced vasoconstriction to norepinephrine and angiotensin II, which may reflect upregulation of receptor-mediated events.
authors.affiliation: Department of Medicine, Manchester Royal Infirmary, United Kingdom.
authors.forename: N
authors.initials: N
authors.lastname: Stephens
authors.forename: M J
authors.initials: MJ
authors.lastname: Drinkhill
authors.forename: A S
authors.initials: AS
authors.lastname: Hall
authors.forename: S G
authors.initials: SG
authors.lastname: Ball
authors.forename: A M
authors.initials: AM
authors.lastname: Heagerty
mesh_terms: D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001158:Arteries / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D002303:Cardiac Output, Low / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D017257:Ramipril / Q000627:therapeutic use; D012867:Skin / Q000098:blood supply*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D017257:Ramipril